An impressive patent certificate does not tell an acquirer whether a business has a defensible advantage. In this Schell IP discussion, Jeff Schell connects patent strategy to product roadmaps, competitor choices, licensing, and acquisition negotiations.
The video emphasizes that portfolio value comes from commercial relevance. A claim directed to a necessary product component may matter more than a larger collection of filings that competitors can easily avoid.
Connect claims to a buyer's business case
Start with the reason a buyer might want the company: a valuable workflow, a product capability, access to customers, or a technical platform. Then ask which issued claims or pending applications support that reason. Keep pending claims distinct from granted rights and identify where additional prosecution or filings may be needed.
Jeff also discusses the difficulty of measuring a competitor's decision to change direction. That possibility is a strategic consideration, not proof that a particular patent caused a specific market result.
Test the portfolio before a transaction
- Map important claims to the current product and plausible next-generation products.
- Evaluate straightforward design-arounds, including changes in materials, interfaces, or process steps.
- Consider whether infringement could be detected from public information or product testing.
- Confirm ownership, prosecution status, geographic coverage, and remaining term.
- Identify restrictions in licenses and other agreements that affect a buyer's intended use.
Avoid promising a valuation multiple
The video includes Jeff's experience with negotiation leverage. An individual experience is not a guaranteed valuation uplift, licensing opportunity, or litigation outcome. A buyer's assessment will depend on the portfolio and the wider business.
The useful deliverable is a supported acquisition narrative: what the portfolio protects, what it does not protect, and why that distinction matters to the buyer. Develop it while there is time to address gaps, rather than during the final diligence sprint.
Related support from Schell IP
- IP support for mergers and acquisitions
- Patent portfolio expansion
This article provides general information. It does not replace legal advice about a particular invention, company, or transaction.
